NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Raleigh's Micell Technologies has drawn the attention--and a $15 million investment--from global medical technologies giant St. Jude Medical.

Micell, which employs 10 people, is developing coating systems that can be used to deliver drugs via medical devices such as the wire-mesh stents now in routine use to open clogged arteries in the heart.

Wes Bonds, Ph.D., a recently retired biotechnology instructor at Western Carolina University who gained nationwide accolades as a creative developer of instructional lessons in genomics, proteomics, DNA sequencing and genetic analysis, died Monday of an apparent heart attack.

Opportunities in marine biotechnology, biofuels, and agricultural biotechnology are among the hopeful targets of North Carolina Public Television special.

The hour-long program aired Sept. 2 on UNC-TV.

Students from the life-science programs at UNC-Chapel Hill and Duke University crowded into the Biotechnology Center today to learn how to make the challenging leap from an academic environment to an industry job.

The attendees got to network with post doctorates currently in the Center's Industrial Fellowship program and mingle with top industry executives from North Carolina's biotechnology companies.

The academic and company laboratories in and around the North Carolina Research Campus will need workers trained in a range of specific techniques.

Enter Rowan-Cabarrus Community College, which today broke ground on a 62,000-square-foot training facility. The community turned out in force for the ceremony, two blocks from the Research Campus' famed core-laboratory facility.

Durham-based drug development firm Addrenex Pharmaceuticals has reported positive results from a second Phase III trial of drug candidate Clonicel, which it hopes to market to treat attention deficit hyperactivity disorder (ADHD).

Sajith Wickramasekara, a student at the North Carolina School of Science and Mathematics in Durham, is one of two Southeastern regional finalists in an international competition of high school biotechnology research projects, held in Atlanta on Monday.

Wickramasekara and the other regional finalist, Johnny Fells III of Georgia, were competing in the Sanofi-Aventis International BioGENEius Challenge, conducted by the Arlington, Va.-based Biotechnology Institute.

Gwyn Riddick, regional director of the Piedmont Triad office of the North Carolina Biotechnology Center, was recently appointed to serve on the Science Advisory Board (SAB) at UNC Greensboro.

The board's mission is to assist the science departments, research centers and laboratories at UNCG to achieve their goals in government/community relations, professional/industry relations, communications and resource development. Members advise, advocate, and open doors on the university's behalf.

All service businesses are hurting for revenues these days, including Contract Research Organizations.

Yonnie Butler, the Biotechnology Center's business development director, had some insight that he thought would help. This issue of Tablets & Capsules contains his advice.

Interested in the promise of biotechnology, but not sure how to bring it to the classroom?

Been teaching science a long time, but looking for some new ideas?

Sign up for one of our annual summer teacher workshops. The week-long classes are held across the state and are open to North Carolina teachers.

A $50 registration fee holds your place, and most workshops pay a stipend and give you access to free laboratory supplies for the coming year.

More Information

Norris Tolson, president and CEO of the North Carolina Biotechnology Center, will be one of three honored with the prestigious Watauga Medal by North Carolina State University for his distinguished service to the university at the university's Founders' Day Dinner March 9.

When our economy recovers, it's a good bet that the biotechnology sector will be one of those sectors leading the way.